A Citric acid, anhydrous (USP) CEP of the European Pharmacopoeia monograph is often referred to as a Citric acid, anhydrous (USP) Certificate of Suitability (COS). The purpose of a Citric acid, anhydrous (USP) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Citric acid, anhydrous (USP) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Citric acid, anhydrous (USP) to their clients by showing that a Citric acid, anhydrous (USP) CEP has been issued for it. The manufacturer submits a Citric acid, anhydrous (USP) CEP (COS) as part of the market authorization procedure, and it takes on the role of a Citric acid, anhydrous (USP) CEP holder for the record. Additionally, the data presented in the Citric acid, anhydrous (USP) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Citric acid, anhydrous (USP) DMF.
A Citric acid, anhydrous (USP) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Citric acid, anhydrous (USP) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Citric acid, anhydrous (USP) suppliers with CEP (COS) on PharmaCompass.